Compare GLAS & PTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | GLAS | PTA |
|---|---|---|
| Founded | N/A | 2020 |
| Country | | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Trusts Except Educational Religious and Charitable |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 908.5M | 1.0B |
| IPO Year | 2021 | N/A |
| Metric | GLAS | PTA |
|---|---|---|
| Price | $9.93 | $18.38 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 329.3K | 132.9K |
| Earning Date | N/A | 01-01-0001 |
| Dividend Yield | N/A | ★ 8.31% |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $9.12 | $18.13 |
| 52 Week High | $12.70 | $20.92 |
| Indicator | GLAS | PTA |
|---|---|---|
| Relative Strength Index (RSI) | 46.80 | 30.78 |
| Support Level | $9.22 | $18.13 |
| Resistance Level | $10.42 | $19.61 |
| Average True Range (ATR) | 0.56 | 0.23 |
| MACD | 0.04 | -0.05 |
| Stochastic Oscillator | 47.62 | 14.45 |
Glass House Brands Inc is an integrated cannabis company that operates exclusively in the state of California. Its portfolio of brands includes Glass House Farms, Forbidden Flowers, and Mama Sue Wellness. It cultivates, manufactures, and distributes cannabis bulk flower and trim to wholesalers and consumer packaged goods to third-party retail stores. It also owns and operates retail cannabis stores in the state of California. It has three reportable segments: Retail, Wholesale Biomass, and Cannabis-related consumer packaged goods. It generates the majority of its revenue from the Wholesale Biomass segment.
COHEN & STEERS TAX-ADV PRD SEC AND INC is a non-diversified, closed-end management statutory trust. Its main investment objective is high current income, and the Fund's secondary investment objective is capital appreciation.